Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laszlo Lakatos

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Expert Opinion on Pharmacotherapy|March 19, 2008
Ulcerative proctitis: a review of pharmacotherapy and managementPeter Laszlo Lakatos, Laszlo Lakatos
Pharmacological Research|September 20, 2008
Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?Peter Laszlo Lakatos, Laszlo Lakatos
World Journal of Gastroenterology|July 9, 2008
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategiesPeter-Laszlo Lakatos, Laszlo Lakatos
World Journal of Gastroenterology|December 12, 2007
Smoking in inflammatory bowel diseases: good, bad or ugly?Peter Laszlo Lakatos, Tamas Szamosi, Laszlo Lakatos
World Journal of Gastroenterology|April 17, 2009
Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun?Peter Laszlo Lakatos
Inflammatory Bowel Diseases|June 12, 2012
Anti-TNFs and severe infections in autoimmune diseases: the other side of the coinPeter Laszlo Lakatos
Reviews on Recent Clinical Trials|December 24, 2009
Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?Peter Laszlo Lakatos
World Journal of Gastroenterology|October 13, 2006
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?Peter-Laszlo Lakatos
Inflammatory Bowel Diseases|December 22, 2009
Management of inflammatory bowel diseases: a changing paradigm. Can we finally change the disease course?Peter Laszlo Lakatos
World Journal of Gastroenterology|September 15, 2009
Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it?Peter Laszlo Lakatos
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Expert Opinion on Pharmacotherapy|March 19, 2008
Ulcerative proctitis: a review of pharmacotherapy and managementPeter Laszlo Lakatos, Laszlo Lakatos
Pharmacological Research|September 20, 2008
Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?Peter Laszlo Lakatos, Laszlo Lakatos
World Journal of Gastroenterology|July 9, 2008
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategiesPeter-Laszlo Lakatos, Laszlo Lakatos
World Journal of Gastroenterology|December 12, 2007
Smoking in inflammatory bowel diseases: good, bad or ugly?Peter Laszlo Lakatos, Tamas Szamosi, Laszlo Lakatos
World Journal of Gastroenterology|April 17, 2009
Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun?Peter Laszlo Lakatos
Inflammatory Bowel Diseases|June 12, 2012
Anti-TNFs and severe infections in autoimmune diseases: the other side of the coinPeter Laszlo Lakatos
Reviews on Recent Clinical Trials|December 24, 2009
Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?Peter Laszlo Lakatos
World Journal of Gastroenterology|October 13, 2006
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?Peter-Laszlo Lakatos
Inflammatory Bowel Diseases|December 22, 2009
Management of inflammatory bowel diseases: a changing paradigm. Can we finally change the disease course?Peter Laszlo Lakatos
World Journal of Gastroenterology|September 15, 2009
Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it?Peter Laszlo Lakatos
Pageof 15